What top creators are saying about Anthropic(ANTH)

Identified as a primary competitor to OpenAI and a top-tier AI holding.

Cited as a significant infrastructure user within the AI wave focused on enterprise readiness.

Identified as a core player in the AI ecosystem shift toward computation as a raw material.

Positioned as primary OpenAI competitor with high operational costs and a business plan described as 'flaky' due to infrastructure spending.

Viewed as a more stable IPO candidate than OpenAI with strong coding capabilities via Claude.

Stronger short-term play than OpenAI with a wild revenue curve and clearer path to free cash flow.

Facing price wars from OpenAI and competition from open-source models that may damage margins ahead of IPO.

Focusing on enterprise-grade intelligence with Claude Fable 5, excelling in long-horizon tasks and autonomous agent development despite controversies over anti-distillation measures.

Expected to compete for market liquidity during its upcoming capital events.

Watching SpaceX performance to benchmark valuation; potential to be viewed as a value play if revenue multiples are more grounded than competitors.

SpaceX IPO is seen as a market precedent for this major tech firm's future valuation.

Recently valued at $965 billion and preparing for a potential public offering.

Facing a brand crisis and enterprise backlash over 'silent nerfing' and data retention policies, creating headwinds for its future IPO.

Recently took the lead in benchmarks with Fable 5 and Mythos 5; preparing for a significant IPO.

Engaged in pricing wars with OpenAI; its upcoming IPO will signal the broader sustainability of AI valuations.

Identified as a high-growth AI competitor to SpaceX.

Consensus enterprise favorite but faces risks from misleading non-GAAP financials and high valuation.

Viewed as a 'non-binary' risk in the AI sector; established enough that failure is unlikely.

Part of a high-growth AI basket seeing 300% growth, though investors are cautioned to size entries as the market may be near a short-term top.

Confidential IPO filing; growing 10x faster than ChatGPT with high revenue efficiency and a strong safety-focused regulatory moat.

Viewed as part of a $4 trillion overvalued private tech bubble; recommendation to sell holdings due to top-of-market risks.

Reportedly filed a confidential S1 for IPO; growth rates are surpassing historical trajectories of major software firms.

Viewed as the fundamental value play with explosive 500% net dollar retention and a clear path to profitability by month-end.

Positioned as an ethical 'frontier lab' with potential to surpass Alphabet's revenue by 2028, though model efficiency remains a concern.

Projected to reach significant revenue run rates alongside OpenAI; central to the 'token path' of AI consumption.

Mentioned as an asset available for trading via tokenized equity on the Hyperliquid platform.

Achieved first quarterly operating profit of $559 million with revenue growing 60% QoQ, treating AI as a metered utility.

Showing hyper-growth with $10 billion in Q2 revenue and achieving a significant milestone of quarterly profitability.

Expected to rent infrastructure from xAI, contributing to xAI's revenue while facing higher capital costs as an equity-dependent rival.

Dependency on equity funding and expected to contribute ~$40B in revenue to xAI for infrastructure rentals.

While the company restricts secondary sales, shares sold by the FTX estate carry lower legal risk; valuation has jumped significantly.

Moving toward an IPO; currently paying significant monthly fees to SpaceX for data center infrastructure.

Paying $1.25 billion per month to SpaceX for compute infrastructure through 2029.

Achieved surprise profitability with $10.9 billion Q2 revenue and strong annualized run rate; validated sustainable scaling model.

Experiencing 130% QoQ revenue growth and reaching profitability, validating the LLM business model.

Rumored upcoming IPO candidate looking to capitalize on current AI market liquidity.

Facing a 'compute wall' after underestimating hardware needs by 8x.

Captures a dominant share of revenue alongside OpenAI in a power law distribution.

Secured a massive compute deal with SpaceX to rival OpenAI; expected to file for an IPO within the year.

Identified as a significant liquidity event in the AI sector that is capturing institutional attention.

Identified as a premier AI sector leader and a must-own candidate that is currently staying private longer than previous tech generations.

Strong secondary market demand indicates high institutional appetite despite competition from the SpaceX/Cursor ecosystem.

Overtaken OpenAI in annual recurring revenue and winning the enterprise war through reliability and strategic cloud partnerships.

Valuation questioned relative to the likelihood of a successful multi-trillion dollar IPO.

Gaining a competitive edge over OpenAI in the enterprise sector with Claude Code and a more cost-effective, focused product roadmap.

Acquired Coefficient Bio for $400 million to expand into AI-driven drug R&D and biotech.

Viewed as a better risk-reward profile than OpenAI with a lower secondary valuation and potential October IPO.

Mentioned as a platform player that vertical AI companies seek to resist disruption from through deep client integration.

Expanding into AI-powered drug discovery through the acquisition of Coefficient Bio.

Seeing increased secondary bids but faces broader market skepticism regarding high-valuation AI startups.